Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8018462rdf:typepubmed:Citationlld:pubmed
pubmed-article:8018462lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:8018462lifeskim:mentionsumls-concept:C1708335lld:lifeskim
pubmed-article:8018462lifeskim:mentionsumls-concept:C0016377lld:lifeskim
pubmed-article:8018462lifeskim:mentionsumls-concept:C0743223lld:lifeskim
pubmed-article:8018462lifeskim:mentionsumls-concept:C0205171lld:lifeskim
pubmed-article:8018462lifeskim:mentionsumls-concept:C0599473lld:lifeskim
pubmed-article:8018462pubmed:issue4lld:pubmed
pubmed-article:8018462pubmed:dateCreated1994-8-4lld:pubmed
pubmed-article:8018462pubmed:abstractTextPlasma concentrations of the enantiomers of flurbiprofen were measured following oral administration of (S)-flurbiprofen 50 mg and (R)-flurbiprofen 50 mg and 100 mg to sixteen healthy subjects. Chiral inversion did not occur to a measurable extent. Significantly higher values of AUC (55.2 +/- 17.0 vs 44.6 +/- 11.2 micrograms ml-1h) elimination half-life (5.6 +/- 1.4 vs 4.0 +/- 1.0 h) and mean residence time (7.5 +/- 1.6 vs 5.7 +/- 1.2 h) were observed after 50 mg (S)-flurbiprofen as compared with 50 mg (R)-flurbiprofen. With the exception of Cmax and AUC values pharmacokinetic data for the 50 mg and the 100 mg dose of (R)-flurbiprofen did not differ significantly. The data are of clinical relevance if (R)-flurbiprofen also has analgesic activity in humans and is to be developed as an analgesic.lld:pubmed
pubmed-article:8018462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:languageenglld:pubmed
pubmed-article:8018462pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:citationSubsetIMlld:pubmed
pubmed-article:8018462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8018462pubmed:statusMEDLINElld:pubmed
pubmed-article:8018462pubmed:monthAprlld:pubmed
pubmed-article:8018462pubmed:issn0306-5251lld:pubmed
pubmed-article:8018462pubmed:authorpubmed-author:BruneKKlld:pubmed
pubmed-article:8018462pubmed:authorpubmed-author:MenzelSSlld:pubmed
pubmed-article:8018462pubmed:authorpubmed-author:KobalGGlld:pubmed
pubmed-article:8018462pubmed:authorpubmed-author:GeisslingerGGlld:pubmed
pubmed-article:8018462pubmed:authorpubmed-author:LötschJJlld:pubmed
pubmed-article:8018462pubmed:issnTypePrintlld:pubmed
pubmed-article:8018462pubmed:volume37lld:pubmed
pubmed-article:8018462pubmed:ownerNLMlld:pubmed
pubmed-article:8018462pubmed:authorsCompleteYlld:pubmed
pubmed-article:8018462pubmed:pagination392-4lld:pubmed
pubmed-article:8018462pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:8018462pubmed:meshHeadingpubmed-meshheading:8018462-...lld:pubmed
pubmed-article:8018462pubmed:meshHeadingpubmed-meshheading:8018462-...lld:pubmed
pubmed-article:8018462pubmed:meshHeadingpubmed-meshheading:8018462-...lld:pubmed
pubmed-article:8018462pubmed:meshHeadingpubmed-meshheading:8018462-...lld:pubmed
pubmed-article:8018462pubmed:meshHeadingpubmed-meshheading:8018462-...lld:pubmed
pubmed-article:8018462pubmed:meshHeadingpubmed-meshheading:8018462-...lld:pubmed
pubmed-article:8018462pubmed:meshHeadingpubmed-meshheading:8018462-...lld:pubmed
pubmed-article:8018462pubmed:meshHeadingpubmed-meshheading:8018462-...lld:pubmed
pubmed-article:8018462pubmed:meshHeadingpubmed-meshheading:8018462-...lld:pubmed
pubmed-article:8018462pubmed:year1994lld:pubmed
pubmed-article:8018462pubmed:articleTitleStereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers.lld:pubmed
pubmed-article:8018462pubmed:affiliationDepartment of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nürnberg, Germany.lld:pubmed
pubmed-article:8018462pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8018462pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8018462pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8018462pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8018462pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8018462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8018462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8018462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8018462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8018462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8018462lld:pubmed